Stereotaxis Stock (AMEX: STXS) stock price, news, charts, stock research, profile.
Open | $2.190 |
Close | $2.180 |
Volume / Avg. | 217.108K / 332.784K |
Day Range | 2.180 - 2.210 |
52 Wk Range | 1.330 - 3.290 |
Market Cap | $179.041M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 36 |
Short Interest | 1.39% |
Days to Cover | 1.59 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Stereotaxis (AMEX: STXS) through any online brokerage.
Other companies in Stereotaxis’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), Semler Scientific (NASDAQ:SMLR), Sight Sciences (NASDAQ:SGHT) and AngioDynamics (NASDAQ:ANGO).
The latest price target for Stereotaxis (AMEX: STXS) was reported by Lake Street on Tuesday, March 5, 2024. The analyst firm set a price target for 4.00 expecting STXS to rise to within 12 months (a possible 81.82% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Stereotaxis (AMEX: STXS) is $2.2 last updated May 10, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Stereotaxis.
Stereotaxis’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Stereotaxis.
Stereotaxis is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the AMEX.